Contact Us
Our Story
History and Milestones
Our Brand
Core Strengths
Vision, Values and Capabilities
Board of Directors
Management Team
Industry Awards and Recognition
Our Businesses
Business Portfolio
API
Domestic Formulations
International Formulations
Manufacturing
Manufacturing Facilities
Quality
Environment, Health and Safety
Scientific Overview
Research and Development
Patents
Therapeutic Focus
Nephrology
Rheumatology
Oncology
Urology
Anti-Diabetic
Respiratory
Gastroenterology
Cardiovascular
Gynaecology and Pediatrics
Vitamins and Minerals
Orthopedic
Neurology
Anti-Dengue
Dermatology
Life@RPGLS
Employee Connect
Rewards and Recognition
Brave RPGLS Covid Warriors
Great Place To Work
Team Awards
Employee Awards
Human Resources
Join Us
Company Events
Learning and Development
CSR
Corporate Social Responsibility
Explore Us
Happiness Matters!!
Investors
Financial Results
Audited Financial Results
Quarterly Financial Results
Company Presentations
Investor Presentations
Corporate Presentations
Earnings Call
Press Release
Mandatory Disclosures
Code and Policies
Shareholders Information
Shareholding Pattern
Concepts and Procedure
Corporate Governance Reports
Annual Reports
Intimation to Stock Exchange
Notices of Board Meetings
Outcome of Board Meetings
AGM & Postal Ballot
Unpaid Dividend List
TDS on Dividend Communication
Forms related to Physical Shares
Newspaper Publications
Market Tracker
Investor Relations
Investor Education and Protection Fund
Investor Grievance
Investor Contacts
Investor Meets
Committees Composition
Audit Committee
Risk Management Committee
Stakeholders Relationship Committee
Nomination & Remuneration Committee
SCSR Committee
DISCLOSURES UNDER REGULATION 46 OF LODR
Disclosures under regulation 46 of LODR
Media
Online News and Print Media
RPGLS @ Industry Platforms
PRODUCT DETAILS
Home
product details
Mofetyl
composition
Mycophenolate Mofetil 250/500 mg tablets
indications
Systemic lupus nephritis (SLE), Nephrotic Syndrome. Rheumatoid Arthritis
Therapeutic Focus
Nephrology
More
Nephrology
Products
Show all
Formulation
API
Arpimune ME
Formulation
Azoran
Formulation
Darba
Formulation
Imunotac
Formulation
Mofetyl-S
Formulation
X-Mab
Formulation
Alfalog
Formulation
Azopen
Formulation
Cilren
Formulation
Ishine XT
Formulation
PPBcc
Formulation
RP-CARN
Formulation
RPO
Formulation
RPTEL
Formulation
Alpha Ketoanalogue
Azathioprine Tablet
Cyclosporine OS
Cyclosporine SGC
Mycophenolate Mofetil
Tacrolimus Capsules
Azathioprine
Mycophenolate Mofetyl
Mycophenolate Sodium
